Ivonescimab Plus Chemotherapy in Patients With EGFR Variant Non-Small Cell Lung Cancer

被引：1
|
作者：
Cheng, Wen-Chien [1 ]
Wang, Guosheng [2 ]
Mei, Qi [3 ]
机构：
[1] China Med Univ, China Med Univ Hosp, Taichung, Taiwan
[2] Shanghai East Hosp, Dept Pulm & Crit Care Med, Shanghai, Peoples R China
[3] Shanxi Med Univ, Shanxi Bethune Hosp, Hosp 3, Canc Ctr, Taiyuan, Peoples R China
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2025年 / 333卷 / 02期
关键词：
D O I：
10.1001/jama.2024.23088
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Ivonescimab Plus Chemotherapy in Patients With EGFR Variant Non-Small Cell Lung Cancer-Reply
    Fang, Wenfeng
    Li, Wenting
    Zhang, Li
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (02):
  • [2] Ivonescimab Plus Chemotherapy in Non-Small Cell Lung Cancer With EGFR Variant A Randomized Clinical Trial
    Fang, Wenfeng
    Zhao, Yuanyuan
    Luo, Yongzhong
    Yang, Runxiang
    Huang, Yan
    He, Zhiyong
    Zhao, Hui
    Li, Mingjun
    Li, Kai
    Song, Qibing
    Du, Xiaobo
    Sun, Yulan
    Li, Wei
    Xu, Fei
    Wang, Zhiyu
    Yang, Kunning
    Fan, Yun
    Liu, Baogang
    Zhao, Hongyun
    Hu, Ying
    Jia, Li
    Xu, Shen
    Yi, Tienan
    Lv, Dongqing
    Lan, Haitao
    Li, Mengxia
    Liang, Wenhua
    Wang, Yongsheng
    Yang, Hui
    Jia, Yuming
    Chen, Yuan
    Lu, Junguo
    Feng, Jifeng
    Liu, Chunling
    Zhou, Ming
    Zhou, Jianya
    Liu, Xianling
    Zhou, Ningning
    He, Ming
    Dong, Xiaorong
    Chen, Hualin
    Chen, Yongxing
    Su, Haichuan
    Li, Xiaoling
    Zhang, Zhihong
    Yang, Lei
    Cheng, Ying
    Chen, Likun
    Hou, Xue
    Zhang, Yu
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (07): : 561 - 570
  • [3] The Role of Lazertinib in Patients With EGFR-Variant Non-Small Cell Lung Cancer
    Cheng, Haiying
    JAMA ONCOLOGY, 2024, 10 (10) : 1352 - 1353
  • [4] Nivolumab plus chemotherapy for non-small cell lung cancer
    Lichert, Frank
    PNEUMOLOGIE, 2024, 78 (02): : 81 - 81
  • [5] Amivantamab Plus Chemotherapy in Non-Small Cell Lung Cancer
    不详
    ONCOLOGY-NEW YORK, 2024, 38 (06):
  • [6] Chemotherapy plus intercalated or continuous EGFR-TKI in advanced non-small cell lung cancer
    Rossi, Antonio
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S659 - S663
  • [7] Investigating osimertinib plus chemotherapy in EGFR-mutated advanced non-small cell lung cancer
    Spagnuolo, Alessia
    Gridelli, Cesare
    EXPERT OPINION ON PHARMACOTHERAPY, 2025,
  • [8] EGFR variant III expression in Chinese patients with non-small cell lung cancer.
    Wang, Jie
    Duan, Jianchun
    Bai, Hua
    Yang, Lu
    An, Tongtong
    Wang, Zhijie
    Zhuo, Minglei
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer
    Felip, Enriqueta
    Metro, Giulio
    Soo, Ross A.
    Wolf, Juergen
    Solomon, Benjamin J.
    Tan, Daniel S. W.
    Ardizzoni, Andrea
    Lee, Dae Ho
    Sequist, Lecia V.
    Barlesi, Fabrice
    Ponce-Aix, Santiago
    Abreu, Delvys Rodriguez
    Campelo, Maria Rosario Garcia
    Sprauten, Mette
    Djentuh, Leslie O'Sullivan
    Smith, Nathalie
    Jary, Aline
    Belli, Riccardo
    Glaser, Sabine
    Zou, Mike
    Cui, Xiaoming
    Giovannini, Monica
    Yang, James Chih-Hsin
    EUROPEAN JOURNAL OF CANCER, 2024, 208
  • [10] Cisplatin plus vinorelbine chemotherapy for non-small cell lung cancer
    Pereira, JR
    Gampel, O
    Martins, SJ
    Ikari, FK
    Nikaedo, SM
    Paschoalini, M
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 643 - 646
12345